Verrica Pharmaceuticals Inc.
Recent Filings
All 513 filings →| Form | Description | Date |
|---|---|---|
| 10-K | 10-K | Mar 11, 2026 |
| 8-K | 8-K | Mar 11, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| 3/A | — | Feb 2, 2026 |
| SCHEDULE 13G/A | — | Jan 29, 2026 |
| 3 | — | Jan 26, 2026 |
| 3 | — | Dec 30, 2025 |
| SCHEDULE 13D/A | — | Dec 30, 2025 |
| 4 | — | Dec 30, 2025 |
| 3 | — | Dec 30, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Date |
|---|---|---|---|---|
| Kirby John J. | Interim CFO | Award / Grant | 10,000 | Dec 23, 2025 |
| Rosenberg Noah L. | CMO | Purchase | 2,357 @ $4.24 | Nov 25, 2025 |
| Kirby John J. | Interim CFO | Purchase | 3,536 @ $4.24 | Nov 25, 2025 |
| Zawitz David | Chief Operating Officer | Purchase | 10,000 @ $4.24 | Nov 25, 2025 |
| Rieger Jayson | CEO and President | Purchase | 94,311 @ $4.24 | Nov 25, 2025 |
| Manning Paul B | — | Purchase | 2,750,762 @ $4.24 | Nov 25, 2025 |
| Hayes Christopher G. | CHIEF LEGAL OFFICER | Sale | 4,315 @ $0.65 | Mar 17, 2025 |
| Rieger Jayson | CEO and President | Purchase | 280,898 | Nov 26, 2024 |
| Stalfort John A III | — | Purchase | 1,123,595 | Nov 26, 2024 |
| Kirby John J. | Interim CFO | Award / Grant | 54,267 | Nov 6, 2024 |